Feasibility and effectiveness of <scp>HCV</scp> viraemia testing at harm reduction sites in Georgia: A prospective three‐arm study

202217 citationsJournal Articlehybrid Open Access

Authors

Sonjelle Shilton · Foundation for Innovative New Diagnostics

Jessica Markby · Foundation for Innovative New Diagnostics

Maia Japaridze · Foundation for Innovative New Diagnostics

Violet Chihota · Foundation for Innovative New Diagnostics

Shaun Shadaker · The Centers

Lia Gvinjilia · Training Programs in Epidemiology and Public Health Interventions Network

Maia Tsereteli

Abstract

Point-of-care viraemia testing and blood drawn on-site for HCVcAg testing yielded more HCV-seropositive patients receiving viraemic testing within a shorter timeframe compared with referrals.

Topics & Keywords

Hepatitis C virus research HIV, Drug Use, Sexual Risk Hepatitis B Virus Studies

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Liver International

Volume 42, Issue 4, pp. 775-786

DOI: 10.1111/liv.15191

Field-Weighted Citation Impact: 2.33